ISC, CAS, Google Scholar     h-index: 20

Document Type : Original Research Article


1 Modern Technical College, Pokhara University, Lalitpur, Nepal

2 School of Health and Allied Sciences, Pokhara University, Kaski, Nepal

3 Amity Medical School, Amity University Haryana, Gurugram, HR, India


Hypertension, a chronic medical condition of elevated blood pressure in the arteries which can be classified as prehypertension and hypertension. Serum gamma-glutamyl transferase (GGT), an enzyme that transfers gamma-glutamyl functional group is a diagnostic marker of liver disease, excessive alcohol consumption, but recently its level was found to be elevated in prehypertension or hypertension.
A total of 315 people were selected for clinic-based comparative Cross-sectional study. Data was generated using a clinical report, physical examination, review of medical and clinical reports, and interviews using a structured questionnaire. The blood sample was withdrawn after proper consent of the study population for measurement of laboratory-based parameters. Serum GGT was estimated using the method described by Persijn and Van der Slik Kinetic spectrophotometric method as recommended by International Federation for Clinical Chemistry. Data was entered and analyzed using SPSS and Excel.
Among 315 study population majority were male and adults. Prevalence of prehypertension and hypertension was relatively high (27.5% and 39.5% respectively). Among the hypertensive population, males (40.2%) and >60 years of age (71.6%) shared a larger percentage. Serum GGT level positively correlates with prehypertension and hypertension with p-value 0.12 and Prevalence of hypertension is increasing with male and older people becoming more prone to hypertension. Serum GGT levels positively correlated with prehypertension and hypertension even after adjustment for age and gender suggesting that GGT level can be used as indicator of prehypertension and hypertension.

Graphical Abstract

Serum Gamma-Glutamyl Transferase and Its Level in Hypertension



[1]  Association AH. Understanding blood pressure readings. 2014.
[2] CA Emdin, SG Anderson, T Callender, N Conrad, G Salimi-Khorshidi, H Mohseni, M Woodward, K Rahimi, Usual blood pressure, peripheral arterial disease, and vascular risk: cohort study of 4.2 million adults, Bmj. (2015 Sep 29) 351.
[3]  N Henningsen, O Ohlsson, I Mattiasson, E Trell, H Kristensson, B Hood, Hypertension, Levels of Serum Gamma Glutamyl Transpeptidase and Degree of Blood Pressure Control in Middle‐Aged Males, Acta medica scandinavica, 207 (1980) 245-251.
[4]  D-H Lee, R Blomhoff, DR Jacobs, Review is serum gamma glutamyltransferase a marker of oxidative stress? Free radical research, 38(6)(2004) 535-53.
[5]  C Courtay, T Oster, F Michelet, A Visvikis, M Diederich, M Wellman, et al., γ-Glutamyltransferase: nucleotide sequence of the human pancreatic cDNA: evidence for a ubiquitous γ-glutamyltransferase polypeptide in human tissues, Biochemical pharmacology, 43(12) (1992) 2527-33.
[6]  G Lum, SR Gambino. Serum gamma-glutamyl transpeptidase activity as an indicator of disease of liver, pancreas, or bone, Clinical Chemistry, 18(4) (1972) 358-362.
[7]  D Giugliano, A Ceriello, G Paolisso, Diabetes mellitus, hypertension, and cardiovascular disease: which role for oxidative stress? Metabolism, 44(3) (1995) 363-368.
[8] JP Persijn, W Slik. A new method for the determination of γ-glutamyltransferase in serum 1976.
[9]  WHO. Global Health Observatory (GHO) data, Data repository Reports, Country statistics, Map gallery, Standards Raised blood pressure, Situation and trends.
[10] Organization WH. A global brief on hypertension: Silent killer, global public health crisis. 2013. URL: http://apps who int/iris/bitstream/10665/79059/ 1/WHO_DCO_WHD_2013 2_eng pdf [accessed 2013-07-17][WebCite Cache ID 6IBqAI2eN]. 2015.
[11]       KK Aryal, Non communicable diseases risk factors: STEPS Survey Nepal 2013-2014.
[12]       S Laurent, P Boutouyrie, R Asmar, I Gautier, B Laloux, L Guize, et al., Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients, Hypertension, 37(5) (2001) 1236-1241.
[13]       M Lida, K Ueda, A Okayama, K Kodama, K Sawai, S Shibata, et al., Impact of elevated blood pressure on mortality from all causes, cardiovascular diseases, heart disease and stroke among Japanese: 14 year follow-up of randomly selected population from Japanese--Nippon data 80, Journal of human hypertension, 17(12) (2003) 851-857.
[14]       K Miura, ML Daviglus, AR Dyer, K Liu, DB Garside, J Stamler, et al., Relationship of blood pressure to 25-year mortality due to coronary heart disease, cardiovascular diseases, and all causes in young adult men: the Chicago Heart Association Detection Project in Industry, Archives of Internal Medicine, 161(12) (2001) 1501-1508.
[15]       K Karki, B Dahal, A Regmi, A Poudel, Y Gurung, WHO STEPS Surveillance: Non Communicable Diseases Risk Factors Survey, 2008. Kathmandu: Ministry of Health and Population, GoN, Society for Local Integrated Development Nepal (SOLID Nepal) and WHO. (2008).
[16]       STEP I. Non Communicable Diseases Risk Factors: STEPS Survey Nepal 2013. 2012.
[17]       CF Liu, YT Gu, HY Wang, NY Fang, Gamma-Glutamyltransferase Level and Risk of Hypertension: A Systematic Review and Meta-Analysis, PLoS ONE, 7(11) (2012).
[18]       A Shankar, J Li, Association between serum gamma-glutamyltransferase level and prehypertension among US adults, Circulation Journal, 71(10) (2007) 1567-1572.
[19]       Y Yamada, E Ikai, I Tsuritani, M Ishizaki, R Honda, M Ishida, The relationship between serum gamma-glutamyl transpeptidase levels and hypertension: common in drinkers and nondrinkers, Hypertension Research, 18(4) (1995) 295-301.
[20]       R Kawamoto, K Kohara, Y Tabara, T Kusunoki, N Otsuka, T Miki, Association between serum gamma-glutamyl transferase level and prehypertension among community-dwelling men, The Tohoku journal of experimental medicine, 216(3) (2008) 213-221.